We recognize that our study has limitations, including the fact that it was an observational study with limited sample size, and that the sensitivity and specificity of the miRNA biomarkers should be compared with conventional NPC markers such as EBV-DNA and VCA-IgA. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.